SEC Comment Letter for Oncocyte Corp (OCX) (CIK 0001642380) (IMDX) — Dec 29, 2015
Oncocyte Corp (OCX) (CIK 0001642380)
Date: Dec. 29, 2015 · CIK: 0001642380 · Accession: 0000000000-15-059777
AI Filing Summary & Sentiment
File numbers found in text: 001-37648
Letter
Mail Stop 4720 December 29 , 2015 Via Email William Annett Chief Executive Officer OncoCyte Corporation 1301 Harbor Bay Parkway, Suite 100 Alameda, California 94502
Re: OncoCyte Corporation Form 10-12B Filed December 21 , 2015 File No. 001-37648
Dear Mr. Annett :
We have completed our review of your filing . We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing include the information the Securities Exchange Act of 1934 and all applicable rules require.
Sincerely,
/s/ Suzanne Hayes
Suzanne Hayes
Assistant Director
Office of Healthcare and Insurance
Show Raw Text
Mail Stop 4720 December 29 , 2015 Via Email William Annett Chief Executive Officer OncoCyte Corporation 1301 Harbor Bay Parkway, Suite 100 Alameda, California 94502 Re: OncoCyte Corporation Form 10-12B Filed December 21 , 2015 File No. 001-37648 Dear Mr. Annett : We have completed our review of your filing . We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing include the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely, /s/ Suzanne Hayes Suzanne Hayes Assistant Director Office of Healthcare and Insurance